Net selling: insiders sold $31M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $4K to $60K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (1)
AQR
$276.2M
added
Sells/Trims (2)
Qube Research
$145.0M
trimmed
Millennium
$136.1M
trimmed
Sells (3)
Tsourapas Panagiotis
$920K
sold
Cahill John T
$389K
sold
Wallace Noel R.
$29.7M
sold
No tracked top-trader positions in CL as of Oct 24, 06:48 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Jul 31, 2026
Financial period
Q2 2026
Earnings per share
$0.95 expected
Revenue
Company release
Estimates as of Oct 23, 2026
EPS expected
$0.89 to $0.96
Revenue expected
13 analysts
Last 30 days
Split both ways
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 31, 2026 | $0.99 / $0.95Alpha Vantage | +4.21% beat | $5.36B No estimate | Unavailable |
| Mar 31, 2026 | May 1, 2026 | $0.97 / $0.94Alpha Vantage | +3.19% beat | $5.32B No estimate | Unavailable |
| Dec 31, 2025 | Jan 30, 2026 | $0.95 / $0.91Alpha Vantage | +4.40% beat | $5.23B No estimate | Unavailable |
| Sep 30, 2025 | Oct 31, 2025 | $0.91 / $0.89Alpha Vantage | +2.25% beat | $5.13B No estimate | Unavailable |
| Jun 30, 2025 | Aug 1, 2025 | $0.92 / $0.89Alpha Vantage | +3.37% beat | $5.11B No estimate | Unavailable |
| Mar 31, 2025 | Apr 25, 2025 | $0.91 / $0.86Alpha Vantage | +5.81% beat | $4.91B No estimate | Unavailable |
| Dec 31, 2024 | Jan 31, 2025 | $0.91 / $0.89Alpha Vantage | +2.25% beat | $4.94B No estimate | Unavailable |
| Sep 30, 2024 | Oct 25, 2024 | $0.91 / $0.88Alpha Vantage | +3.41% beat | $5.03B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $5.13B | $5.23B | $5.32B | $5.36B |
| Cost of what it sold | $2.08B | $2.08B | $2.10B | $2.06B |
| Gross profit | $3.05B | $3.15B | $3.23B | $3.30B |
| What it spent | ||||
| Sales and admin | $1.32B | $1.98B | $2.08B | $2.13B |
| Other operating costs | $634.0M | $90.0M | — | $150.0M |
| Total operating expenses | $1.95B | $2.07B | $2.08B | $2.28B |
| What was left | ||||
| Operating profit | $1.10B | $1.08B | $1.16B | $1.02B |
| Interest on debt | $67.0M | $64.0M | $62.0M | $62.0M |
| Profit before tax | $992.0M | $107.0M | $892.0M | $950.0M |
| Tax | $226.0M | $112.0M | $211.0M | $231.0M |
| Net profit | $735.0M | -$37.0M | $646.0M | $693.0M |
| EBITDA | $1.22B | $344.0M | $1.11B | $1.17B |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Kimberly-Clark (NYSE:KMB) Rallies After Strong Preliminary Quarterly Update
Leans bullishOct 22Colgate-Palmolive India appoints Akash Parekh as EVP-Marketing, Gunjit Jain to exit
Leans bullishOct 22Gunjit Jain resigns as Colgate-Palmolive India's EVP, Marketing, after 18 years
NeutralOct 22Colgate-Palmolive Q2 net profit up 5.5% to Rs.342 crore, narrowly misses estimates
NeutralOct 22Akash Parekh is Colgate-Palmolive’s new EVP of marketing
Leans bullishOct 22Church & Dwight stock hits 52-week high at 106.24 USD
Leans bullishOct 22Colgate Palmolive India Q2 profit rises 4 per cent as sales grow 12.2 per cent
BullishOct 22Colgate-Palmolive India names Akash Parekh EVP – Marketing
Leans bullishOct 22